Association between immunity and prognostic factors in early stage breast cancer patients before adjuvant treatment

被引：0
|
作者：
Marzio E.E. Sabbioni
Hans Peter Siegrist
Marisa Bacchi
Jürg Bernhard
Monica Castiglione
Beat Thürlimann
Hervé Bonnefoi
Lucien Perey
Richard Herrmann
Aron Goldhirsch
Christoph Hürny
机构：
[1] University HospitalInselspital,Medical Division Lory
[2] Medizinisch-chemisches Labor,Haus
[3] IBCSG,Medical Department C
[4] Biometrics,Gynecology Department
[5] Ares-Serono International S.A.,Oncology Department
[6] Kantonsspital,Oncology Division
[7] University Hospital Geneva,undefined
[8] University Hospital Lausanne,undefined
[9] University Hospital Basel,undefined
[10] Bürgerspital,undefined
来源：
Breast Cancer Research and Treatment | 2000年 / 59卷
关键词：
breast cancer; cellular immunity; β; -microglobulin; sIL-2r; prognosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Objective: The association of known prognostic factors with immune cell counts and β2-microglobulin and soluble IL-2 receptor (sIL-2r) serum levels as markers of activation of the immune system was investigated in breastcancer.
引用
收藏
页码：279 / 287
页数：8
相关论文
共 50 条
  • [1] Association between immunity and prognostic factors in early stage breast cancer patients before adjuvant treatment
    Sabbioni, MEE
    Siegrist, HP
    Bacchi, M
    Bernhard, J
    Castiglione, M
    Thürlimann, B
    Bonnefoi, H
    Perey, L
    Herrmann, R
    Goldhirsch, A
    Hürny, C
    BREAST CANCER RESEARCH AND TREATMENT, 2000, 59 (03) : 279 - 287
  • [2] Surgically treated early stage cervical cancer - Prognostic factors and adjuvant treatment
    Ruchika, Verneker A.
    Arun, Desai J.
    Shilpa, Patel M.
    INTERNATIONAL JOURNAL OF MEDICAL RESEARCH & HEALTH SCIENCES, 2016, 5 (01): : 180 - 183
  • [3] Adjuvant treatment results and prognostic factors in patients with stage I-III operated breast cancer
    Izmirli, Mustafa
    Donmez Yilmaz, Binnur
    Alan, Omur
    Yalciner, Mehmet
    Berberoglu, Elif
    Unsal, Mustafa
    TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY, 2006, 21 (02): : 72 - 80
  • [4] Prognostic & predictive factors for planning adjuvant chemotherapy of early-stage breast cancer
    Esbah, Onur
    Oksuzoglu, Berna
    INDIAN JOURNAL OF MEDICAL RESEARCH, 2017, 146 : 563 - 571
  • [5] Prognostic and predictive factors in the adjuvant treatment of breast cancer
    Fukutomi T.
    Breast Cancer, 2002, 9 (2) : 95 - 99
  • [6] Adjuvant Treatment with Denosumab in Breast Cancer at an Early Stage
    Ruchalla, Elke
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2016, 76 (02)
  • [7] More prognostic factors in early stage breast cancer
    Mizrak, D.
    Ozturk, B.
    Kubilay, P.
    Akbulut, H.
    Onur, H.
    BREAST, 2015, 24 : S122 - S123
  • [8] Routine Cardiac Evaluation in Patients With Early-Stage Breast Cancer Before Adjuvant Chemotherapy
    Jeyakumar, Alwin
    DiPenta, Jillian
    Snow, Stephanie
    Rayson, Daniel
    Thompson, Kara
    Theriault, Chris
    Younis, Tallal
    CLINICAL BREAST CANCER, 2012, 12 (01) : 4 - 9
  • [9] Prognostic Assessment and Adjuvant Treatment Strategies Within Early-Stage, Sporadic Triple Negative Breast Cancer Patients
    Koenigsberg, Robert
    Pfeiler, Georg
    Kurzawa, Roland
    Hudec, Marcus
    Zeillinger, Robert
    Dittrich, Christian
    Singer, Christian
    CANCER INVESTIGATION, 2011, 29 (02) : 180 - 186
  • [10] The role of taxanes in the adjuvant treatment of early stage breast cancer
    Piccart, M
    BREAST CANCER RESEARCH AND TREATMENT, 2003, 79 : S25 - S34
12345